Header Logo

Connection

Nell Lurain to Cytomegalovirus Infections

This is a "connection" page, showing publications Nell Lurain has written about Cytomegalovirus Infections.
Connection Strength

4.210
  1. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women. AIDS Res Hum Retroviruses. 2016 Feb; 32(2):134-43.
    View in: PubMed
    Score: 0.488
  2. Reply to Itzhaki and Klapper. J Infect Dis. 2014 Mar; 209(6):974.
    View in: PubMed
    Score: 0.428
  3. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013 Aug 15; 208(4):564-72.
    View in: PubMed
    Score: 0.412
  4. Introduction to the special issue dedicated to the 11th International CMV and Beta Herpesvirus Workshop. J Clin Virol. 2008 Mar; 41(3):173.
    View in: PubMed
    Score: 0.287
  5. Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology. 2007 Dec 05; 369(1):55-68.
    View in: PubMed
    Score: 0.277
  6. HIV type 1 and cytomegalovirus coinfection in the female genital tract. J Infect Dis. 2004 Aug 01; 190(3):619-23.
    View in: PubMed
    Score: 0.223
  7. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. J Infect Dis. 2002 Sep 15; 186(6):760-8.
    View in: PubMed
    Score: 0.196
  8. Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events. AIDS. 2020 05 01; 34(6):849-857.
    View in: PubMed
    Score: 0.167
  9. Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol. 1999 Dec; 73(12):10040-50.
    View in: PubMed
    Score: 0.162
  10. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2018 08 16; 67(5):770-777.
    View in: PubMed
    Score: 0.148
  11. Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication. J Virol. 2016 Dec 01; 90(23):10715-10727.
    View in: PubMed
    Score: 0.131
  12. Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor. Transplantation. 1996 Aug 27; 62(4):497-502.
    View in: PubMed
    Score: 0.129
  13. Soluble CD163 But Not Soluble CD14 Is Associated With Cytomegalovirus Immunoglobulin G Antibody Levels in Virologically Suppressed HIV+ Individuals. J Acquir Immune Defic Syndr. 2015 Dec 15; 70(5):e171-4.
    View in: PubMed
    Score: 0.123
  14. Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients. Transpl Infect Dis. 2014 Dec; 16(6):941-50.
    View in: PubMed
    Score: 0.115
  15. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis. 2012 Jun 15; 205(12):1788-96.
    View in: PubMed
    Score: 0.095
  16. Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J Virol. 2011 Dec; 85(24):13204-13.
    View in: PubMed
    Score: 0.092
  17. Cytomegalovirus viraemia in the modern antiretroviral era(*). HIV Med. 2011 Aug; 12(7):387-8.
    View in: PubMed
    Score: 0.091
  18. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010 Oct; 23(4):689-712.
    View in: PubMed
    Score: 0.086
  19. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes. Transplantation. 2010 Aug 27; 90(4):419-26.
    View in: PubMed
    Score: 0.085
  20. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008 May 01; 46(9):1455-7.
    View in: PubMed
    Score: 0.073
  21. Evaluation of real-time PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification. J Clin Microbiol. 2007 Jun; 45(6):1723-7.
    View in: PubMed
    Score: 0.067
  22. Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency. J Pediatr Hematol Oncol. 2004 Sep; 26(9):601-5.
    View in: PubMed
    Score: 0.056
  23. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum Immunol. 2004 May; 65(5):403-9.
    View in: PubMed
    Score: 0.055
  24. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant. 2002 Dec; 21(12):1274-82.
    View in: PubMed
    Score: 0.050
  25. Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection. Transpl Infect Dis. 2002 Dec; 4(4):189-94.
    View in: PubMed
    Score: 0.050
  26. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood. 2003 Jan 15; 101(2):463-5.
    View in: PubMed
    Score: 0.049
  27. Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol. 2001 Apr; 39(4):1334-8.
    View in: PubMed
    Score: 0.044
  28. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999 Sep 27; 68(6):814-25.
    View in: PubMed
    Score: 0.010
  29. Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol. 1999 Jun 15; 162(12):6967-70.
    View in: PubMed
    Score: 0.010
  30. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 1999; 42(5-6):412-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.